<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03544242</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-160901003</org_study_id>
    <nct_id>NCT03544242</nct_id>
  </id_info>
  <brief_title>Nitrite Infusion in Islet Cell Transplantation</brief_title>
  <official_title>Nitrite Infusion in Islet Cell Transplantation: Test of Clinical Efficacy and Determination of Cytoprotective Mechanisms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to investigate the effects of administering nitrite to pancreatic islet&#xD;
      cells that have been removed from a patient for autotransplantation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients diagnosed with chronic pancreatitis or recurrent acute pancreatitis may acquire&#xD;
      insulin-dependent diabetes due to islet cell destruction. Therefore, islet cell&#xD;
      autotransplantation is the optimal therapeutic approach for many of these patients. Islet&#xD;
      cell autotransplantation is typically done by excision of the pancreas, followed by isolation&#xD;
      of the islet cells and then infusion of these cells into the sinusoids of the liver.&#xD;
      Isolation of the islet cells occurs in an ischemic and hypoxic environment, resulting in&#xD;
      ischemia reperfusion (IR) injury and destruction of islet cells following infusion into the&#xD;
      sinusoids. Hence, strategies to prevent IR injury and subsequent islet cell destruction, such&#xD;
      as the administration of inhaled nitric oxide (NO) or sodium nitrite (NaNO2) could enhance&#xD;
      islet cell survival following reperfusion, also decreasing long-term insulin requirement. The&#xD;
      purpose of this study is to determine if NO administered by infusion in patients undergoing&#xD;
      islet cell auto transplantation, will inhibit islet cell destruction, increase diabetes cure&#xD;
      rate (decrease the amount of and/or the need for long-term insulin requirement), decrease the&#xD;
      ischemic injury (reduces the injury to the islet cells from a decrease in oxygen levels&#xD;
      during procurement of the islet cells) during islet cell procurement, and decrease IR injury&#xD;
      following islet cell infusion. The primary endpoints of the study are exogenous insulin use,&#xD;
      HgbA1c levels post-operatively, and blood glucose levels.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of eligible subjects, lack of staffing&#xD;
  </why_stopped>
  <start_date type="Actual">May 7, 2017</start_date>
  <completion_date type="Actual">June 27, 2019</completion_date>
  <primary_completion_date type="Actual">June 27, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prior to Infusion Blood Glucose Serum Levels</measure>
    <time_frame>Between the time of induction and the time immediately prior to infusion of either nitrite or saline</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pre-islet Cell Infusion Blood Serum Glucose Levels</measure>
    <time_frame>Five minutes prior to the infusion of islet cells</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>20 Minutes After Islet Cells Blood Serum Glucose Levels</measure>
    <time_frame>20 minutes after the infusion of Islet Cells</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>40 Minutes After Islet Cells Blood Serum Glucose Levels</measure>
    <time_frame>40 minutes after the infusion of Islet Cells</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>24 Hours Post Operative Blood Samples Serum Glucose Levels</measure>
    <time_frame>24 hours post operatively</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>48 Hours Post Operative Blood Samples Serum Glucose Levels</measure>
    <time_frame>48 hours post operatively</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>72 Hours Post Operative Blood Samples Serum Glucose Levels</measure>
    <time_frame>72 hours post operatively</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>96 Hours Post Operative Blood Samples Serum Glucose Levels</measure>
    <time_frame>96 hours post operatively</time_frame>
    <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Pre-Isolation Infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-Isolation Infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pre-Isolation Infusion</intervention_name>
    <description>A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
    <arm_group_label>Pre-Isolation Infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Post-Isolation Infusion</intervention_name>
    <description>A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
    <arm_group_label>Post-Isolation Infusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients greater than or equal to 18 years of age&#xD;
&#xD;
          -  Scheduled to undergo Islet Cell auto-transplantation by Dr. Jared White or Dr. Bart&#xD;
             Rose&#xD;
&#xD;
          -  Subjects who can provide informed written consent and are willing to do so&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -Any patient with liver disease or unsuitable for surgery (as determined by the surgeon)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Blair Smith, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>May 21, 2018</study_first_submitted>
  <study_first_submitted_qc>May 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2018</study_first_posted>
  <results_first_submitted>August 3, 2020</results_first_submitted>
  <results_first_submitted_qc>August 3, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 18, 2020</results_first_posted>
  <last_update_submitted>October 7, 2020</last_update_submitted>
  <last_update_submitted_qc>October 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Blair Smith</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Insulin Resistance</keyword>
  <keyword>Nitrite</keyword>
  <keyword>Pancreatic islet cells</keyword>
  <keyword>Autotransplantation</keyword>
  <keyword>Ischemia reperfusion injury</keyword>
  <keyword>Mitigation</keyword>
  <keyword>Cure</keyword>
  <keyword>Nitric oxide</keyword>
  <keyword>Sodium nitrite</keyword>
  <keyword>Islet cell</keyword>
  <keyword>Survival</keyword>
  <keyword>Pancreas</keyword>
  <keyword>Liver</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 17, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/42/NCT03544242/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control Group</title>
          <description>Control: A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
        </group>
        <group group_id="P2">
          <title>Pre-Isolation Infusion</title>
          <description>Pre-Isolation Infusion: A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
        </group>
        <group group_id="P3">
          <title>Post-Isolation Infusion</title>
          <description>Post-Isolation Infusion: A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control Group</title>
          <description>Control: A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
        </group>
        <group group_id="B2">
          <title>Pre-Isolation Infusion</title>
          <description>Pre-Isolation Infusion: A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
        </group>
        <group group_id="B3">
          <title>Post-Isolation Infusion</title>
          <description>Post-Isolation Infusion: A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
            <count group_id="B2" value="1"/>
            <count group_id="B3" value="2"/>
            <count group_id="B4" value="4"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Prior to Infusion Blood Glucose Serum Levels</title>
        <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
        <time_frame>Between the time of induction and the time immediately prior to infusion of either nitrite or saline</time_frame>
        <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Control: A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
          </group>
          <group group_id="O2">
            <title>Pre-Isolation Infusion</title>
            <description>Pre-Isolation Infusion: A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
          </group>
          <group group_id="O3">
            <title>Post-Isolation Infusion</title>
            <description>Post-Isolation Infusion: A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
          </group>
        </group_list>
        <measure>
          <title>Prior to Infusion Blood Glucose Serum Levels</title>
          <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
          <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pre-islet Cell Infusion Blood Serum Glucose Levels</title>
        <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
        <time_frame>Five minutes prior to the infusion of islet cells</time_frame>
        <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Control: A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
          </group>
          <group group_id="O2">
            <title>Pre-Isolation Infusion</title>
            <description>Pre-Isolation Infusion: A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
          </group>
          <group group_id="O3">
            <title>Post-Isolation Infusion</title>
            <description>Post-Isolation Infusion: A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
          </group>
        </group_list>
        <measure>
          <title>Pre-islet Cell Infusion Blood Serum Glucose Levels</title>
          <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
          <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>20 Minutes After Islet Cells Blood Serum Glucose Levels</title>
        <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
        <time_frame>20 minutes after the infusion of Islet Cells</time_frame>
        <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Control: A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
          </group>
          <group group_id="O2">
            <title>Pre-Isolation Infusion</title>
            <description>Pre-Isolation Infusion: A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
          </group>
          <group group_id="O3">
            <title>Post-Isolation Infusion</title>
            <description>Post-Isolation Infusion: A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
          </group>
        </group_list>
        <measure>
          <title>20 Minutes After Islet Cells Blood Serum Glucose Levels</title>
          <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
          <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>40 Minutes After Islet Cells Blood Serum Glucose Levels</title>
        <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
        <time_frame>40 minutes after the infusion of Islet Cells</time_frame>
        <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Control: A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
          </group>
          <group group_id="O2">
            <title>Pre-Isolation Infusion</title>
            <description>Pre-Isolation Infusion: A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
          </group>
          <group group_id="O3">
            <title>Post-Isolation Infusion</title>
            <description>Post-Isolation Infusion: A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
          </group>
        </group_list>
        <measure>
          <title>40 Minutes After Islet Cells Blood Serum Glucose Levels</title>
          <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
          <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>24 Hours Post Operative Blood Samples Serum Glucose Levels</title>
        <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
        <time_frame>24 hours post operatively</time_frame>
        <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Control: A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
          </group>
          <group group_id="O2">
            <title>Pre-Isolation Infusion</title>
            <description>Pre-Isolation Infusion: A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
          </group>
          <group group_id="O3">
            <title>Post-Isolation Infusion</title>
            <description>Post-Isolation Infusion: A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
          </group>
        </group_list>
        <measure>
          <title>24 Hours Post Operative Blood Samples Serum Glucose Levels</title>
          <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
          <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>48 Hours Post Operative Blood Samples Serum Glucose Levels</title>
        <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
        <time_frame>48 hours post operatively</time_frame>
        <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Control: A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
          </group>
          <group group_id="O2">
            <title>Pre-Isolation Infusion</title>
            <description>Pre-Isolation Infusion: A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
          </group>
          <group group_id="O3">
            <title>Post-Isolation Infusion</title>
            <description>Post-Isolation Infusion: A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
          </group>
        </group_list>
        <measure>
          <title>48 Hours Post Operative Blood Samples Serum Glucose Levels</title>
          <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
          <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>72 Hours Post Operative Blood Samples Serum Glucose Levels</title>
        <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
        <time_frame>72 hours post operatively</time_frame>
        <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Control: A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
          </group>
          <group group_id="O2">
            <title>Pre-Isolation Infusion</title>
            <description>Pre-Isolation Infusion: A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
          </group>
          <group group_id="O3">
            <title>Post-Isolation Infusion</title>
            <description>Post-Isolation Infusion: A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
          </group>
        </group_list>
        <measure>
          <title>72 Hours Post Operative Blood Samples Serum Glucose Levels</title>
          <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
          <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>96 Hours Post Operative Blood Samples Serum Glucose Levels</title>
        <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
        <time_frame>96 hours post operatively</time_frame>
        <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Control: A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
          </group>
          <group group_id="O2">
            <title>Pre-Isolation Infusion</title>
            <description>Pre-Isolation Infusion: A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
          </group>
          <group group_id="O3">
            <title>Post-Isolation Infusion</title>
            <description>Post-Isolation Infusion: A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
          </group>
        </group_list>
        <measure>
          <title>96 Hours Post Operative Blood Samples Serum Glucose Levels</title>
          <description>Blood serum glucose levels will be measured from a blood sample of the amount of 3-5 cc.</description>
          <population>The study did not reach sufficient enrollment power for statistical analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>from baseline through 24 months post-operatively</time_frame>
      <desc>Patients were evaluated for adverse events during appointments.</desc>
      <group_list>
        <group group_id="E1">
          <title>Control Group</title>
          <description>Control: A saline infusion will be administered during the pre-isolation and post-isolation phases.</description>
        </group>
        <group group_id="E2">
          <title>Pre-Isolation Infusion</title>
          <description>Pre-Isolation Infusion: A nitrite infusion will be administered during the pre-isolation phase and a saline infusion will be administered during the post-isolation phase.</description>
        </group>
        <group group_id="E3">
          <title>Post-Isolation Infusion</title>
          <description>Post-Isolation Infusion: A saline infusion will be administered during the pre-isolation phase and a nitrite infusion will be administered during the reperfusion phase.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Adam Sturdivant, MPH</name_or_title>
      <organization>University of Alabama at Birmingham</organization>
      <phone>205-934-4042</phone>
      <email>Adamsturdivant@uabmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

